University of Michigan Rogel Cancer Center — Ann Arbor, Michigan

University of Michigan Rogel Cancer Center is a clinical research site located in Ann Arbor, Michigan, United States 48109.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Michigan Rogel Cancer Center has participated in 218 clinical trials with 161 currently active.

Therapeutic areas: Prostate Cancer, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1.

Sponsors: University of Michigan Rogel Cancer Center, Children's Oncology Group, Zenith Epigenetics.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Michigan Rogel Cancer Center?

University of Michigan Rogel Cancer Center has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Michigan Rogel Cancer Center conducted?

University of Michigan Rogel Cancer Center has 218 clinical trials on record, with 161 currently active. Their work covers Prostate Cancer, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1.

Is University of Michigan Rogel Cancer Center accredited by Crixeo Health?

University of Michigan Rogel Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Michigan Rogel Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.